Kelly Chase is battling round two of leukemia, but he's turning it around into a positive to raise money for Siteman Cancer ...

During his freshman year at Salem State University, Aidan Lynch brought up an important event about his family, the Red Cross Blood Drive at North Andover High, to his college roommates. The blood ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

Lisa Guarino claimed the TV personality expressed how “grateful” she was to have a friend like her in prison and vowed to ...

Elizabeth Busten has been fighting leukemia since 2016. For years, she’s gone back and forth between Tulsa and Oklahoma City ...

Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...

SYRS stock plummets as late-stage cancer study of lead candidate fails to achieve its primary endpoint leading to the termination of the study.

Alicia Fivecoat, 62, from Texas, was devastated when she was diagnosed with breast cancer late last year after discovering a ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...